Genmark Diagnostics

Genmark Diagnostics EPS

Delisted

The Earnings per Share (EPS) of Genmark Diagnostics (GNMK) as of Oct 10, 2026 is -0.27 USD. In the previous year, Earnings per Share (EPS) was -0.82 USD — a change of -66.42% (higher).

EPS

-0.27USD

YoY

-66.42%

Last updated:

Earnings per Share (EPS) of Genmark Diagnostics is 2020 -0.27 USD. Earnings per Share (EPS) of Genmark Diagnostics was 2019 -0.82 USD. It decreases by -66.42% higher compared to the previous year.

The Genmark Diagnostics EPS history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EPS
Date
EPS
Jan 1, 2018
-0.90 USD
Jan 1, 2019
-0.82 USD
Jan 1, 2020
-0.27 USD
Jan 1, 2021 (e)
0.00 USD
Jan 1, 2022 (e)
0.00 USD
Jan 1, 2023 (e)
0.00 USD
Jan 1, 2024 (e)
0.00 USD
Jan 1, 2025 (e)
0.00 USD
The Genmark Diagnostics EPS history
YEAREPSYoY
est0.00USD—
est0.00USD—
est0.00USD—
est0.00USD—
est0.00USD-100.00%
-0.27USD-66.42%
-0.82USD-9.47%
-0.90USD-25.64%
-1.21USD+5.45%
-1.15USD+14.47%
-1.00USD+7.66%
-0.93USD-2.91%
-0.96USD+13.07%
-0.85USD-39.71%
-1.41USD-23.38%
-1.84USD-58.27%
-4.41USD-84.32%
-28.13USD—
Access this data via the Eulerpool API
Get Free API Key

Genmark Diagnostics Stock analysis

What does Genmark Diagnostics do? The company Genmark Diagnostics was founded in 1999 in California, USA. Its goal is to develop and produce diagnostic and testing solutions for the medical and biotechnology industries, with a focus on microfluidic technology. The company offers comprehensive services from the development of diagnostic and testing solutions to the production of devices and systems. Its main business areas are molecular diagnostics, laboratory test automation, and genomics. Genmark Diagnostics provides a variety of test solutions for diseases in the field of molecular diagnostics, as well as automation platforms for laboratory testing and products for genomic analysis. The company's products, such as the ePlex® system, aim to improve the accuracy and speed of medical diagnostics. Genmark Diagnostics is headquartered in Carlsbad, California, USA and has international branches. Its mission is to enhance the accuracy and speed of medical diagnostics worldwide through innovative devices and systems. Genmark Diagnostics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Genmark Diagnostics stock

Earnings per Share (EPS) of Genmark Diagnostics is -0.27 USD in 2020.

Earnings per Share (EPS) of Genmark Diagnostics changed from -0.82 USD to -0.27 USD, representing a -66.42% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Earnings per Share (EPS) Genmark Diagnostics since 2006 – with annual values, charts, and detailed analysis.

Earnings per Share measures the portion of a company's profit allocated to each outstanding share. It is a key metric for assessing a company's profitability on a per-share basis.

EPS = Net Income / Shares Outstanding

Access this data via the Eulerpool API
Get Free API Key

Income Statement — Genmark Diagnostics

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Genmark Diagnostics